TGFb2 induces the soluble isoform of CTLA-4 – implications for CTLA-4 based checkpoint inhibitor antibodies in malignant melanoma
Citation
Khanolkar , R C , Zhang , C , al-Fatyan , F , Lawson , L G , Depasquale , I , Meredith , F , Muller , F , Nicolson , M , Dahal , L N , Abu Eid , R , Rajpara , S , Barker , R N , Ormerod , A & Ward , F J 2022 , ' TGFb2 induces the soluble isoform of CTLA-4 – implications for CTLA-4 based checkpoint inhibitor antibodies in malignant melanoma ' , Frontiers in Immunology , vol. 12 , 763877 . https://doi.org/10.3389/fimmu.2021.763877
Rights
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.https://creativecommons.org/licenses/by/4.0/